Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Multiple Sclerosis

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1191/1352458503ms970oaPMID 14664469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-β2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System1

  2003cited by this paper
• Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

  2003cited by this paper
• Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes1

  2002cited by this paper
• Effect of phosphodiesterase inhibitors on nitric oxide production by glial cells.

  2002cited by this paper
• Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.

  2001cited by this paper
• Phosphodiesterase 4 Inhibitors Prevent Cytokine Secretion by T Lymphocytes by Inhibiting Nuclear Factor-κB and Nuclear Factor of Activated T Cells Activation

  2001cited by this paper
• Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin‐12 production and major histocompatibility complex II expression

  2001cited by this paper
• The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.

  2000cited by this paper
• Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis.

  2000cited by this paper
• Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors

  2000cited by this paper
• Effects of vesnarinone on cytokine production and activation of murine microglia.

  1999cited by this paper
• Regulation of IL-15-stimulated TNF-alpha production by rolipram.

  1999cited by this paper
• Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats.

  1999cited by this paper
• Effects of phosphodiesterase inhibitors on cytokine production by microglia

  1999cited by this paper
• Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.

  1999cited by this paper
• Regulation of IL-15-Stimulated TNF-α Production by Rolipram

  1999cited by this paper
• Ibudilast suppresses TNFα production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS

  1999cited by this paper
• Propentofylline inhibits production of TNFalpha and infection of LP-BM5 murine leukemia virus in glial cells.

  1998cited by this paper
• Production of interleukin-12 and expression of its receptors by murine microglia.

  1998cited by this paper
• Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development.

  1998cited by this paper
• In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

  1998cited by this paper
• Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis

  1998cited by this paper
• Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents.

  1997cited by this paper
• Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription.

  1997cited by this paper
• T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta.

  1994cited by this paper
• T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin‐12 and interferon‐γ and is inhibited by transforming growth factor‐β

  1994cited by this paper
• Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐ but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

  1993cited by this paper
• Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.

  1993cited by this paper
• Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.

  1993cited by this paper
• Immunological aspects of demyelinating diseases.

  1992cited by this paper
• Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

  1991cited by this paper
• Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.

  1988cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by γ-interferon

  1987cited by this paper

• Microglial NOX2 as a therapeutic target in traumatic brain injury: Mechanisms, Consequences, and Potential for Neuroprotection.

  2025cites this paper
• Regulation of oxygen–glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin

  2023influential citation
• A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis

  2022cites this paper
• HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART

  2022cites this paper
• A comprehensive study to delineate the role of an extracellular vesicle‐associated microRNA‐29a in chronic methamphetamine use disorder

  2021cites this paper
• Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis

  2019cites this paper
• inhibits chemokine expression in rheumatoid synovial fibroblasts and exhibits immunomodulatory activity in experimental

  2018influential citation
• Ibudilast: a non‑selective phosphodiesterase inhibitor in brain disorders.

  2017cites this paper
• Ibudilast for the treatment of multiple sclerosis

  2016cites this paper
• Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

  2016cites this paper
• Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking.

  2016cites this paper
• The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders

  2015cites this paper
• Opportunities for the development of neuroimmune therapies in addiction.

  2014cites this paper
• Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis

  2009cites this paper
• Production of interferon-gamma by microglia.

  2006cites this paper
• Production of interferon-γ by microglia

  2006cites this paper
• Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors

  2005cites this paper
• Effects of interferon-β on microglial functions as inflammatory and antigen presenting cells in the central nervous system

  2004cites this paper
• Inhibiting cytokines of the interleukin‐12 family: recent advances and novel challenges

  2004cites this paper
• Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system.

  2004cites this paper
• Regulation of OGD/R-induced in�ammatory responses and M1-M2 phenotype switch of BV2 microglia by Lobetyolin

  year unknowncites this paper